Earnings reset and guidance cut put Clorox’s near term in focus

Clorox (CLX) recently reported mixed third quarter results and sharply reduced its full year earnings outlook, a combination that put margin pressures and execution questions front and center for stock investors.

The updated outlook helped drive a 14.19% 30 day share price decline and a 23.47% 90 day share price return, while the 1 year total shareholder return of 31.08% loss underlines that momentum has been fading for some time.

If Clorox's reset has you rethinking where growth and income might balance differently, this can be a useful moment to scan 19 top founder-led companies

With the stock down sharply over 1 year yet trading at an apparent 47% intrinsic discount, the key question for you is simple: is this a reset that opens up value, or is the market already pricing in future growth?

Most Popular Narrative: 22% Undervalued

The widely followed narrative values Clorox at $115.47 per share versus the last close of $90.01, putting the current reset against a higher long term earnings profile.

The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies, improving supply chain visibility, speeding innovation cycles, and reducing structural costs, which should support margin expansion and sustained earnings growth once short-term transition noise normalizes.

Want to see what sits behind that confidence in higher margins and earnings power? The narrative leans on compounding revenue growth, firmer profitability, and a richer future earnings multiple.

Result: Fair Value of $115.47 (UNDERVALUED)

However, you still need to weigh slower category growth and intense price competition, which could pressure margins and challenge the assumptions regarding higher earnings and valuation multiples.

Next Steps

With sentiment clearly mixed, this is a good time to look at the numbers yourself, weigh the concerns against the potential, and review the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If this reset has you reassessing Clorox, do not stop here. Use this moment to widen your watchlist and compare other opportunities side by side.

• Spot potential value early by scanning screener containing 23 high quality undiscovered gems before others start paying attention.
• Strengthen your core holdings by checking stocks in the solid balance sheet and fundamentals stocks screener (45 results) that could handle tougher conditions.
• Focus on income potential by reviewing companies in the 12 dividend fortresses that might suit a yield oriented approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.